Phase 4 N=600 Patient Satisfaction With Propofol for Out Patient Colonoscopy
Colon Cancer · IBS · Polyps
Primary: Patient Satisfaction — 259; 222; 37; 66 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=55 Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II
Bipolar II Disorder
Primary: Percentage of Participants With >=50% Improvement From Baseline in Clinical Global Impression for Bipolar Disorders Overall Severity — 37; 21 percentage of participants
Phase 4 N=96 Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)
Herpes Zoster
Primary: Geometric Mean Titre (GMT) of Varicella Antibodies — 215.8; 674.0 gpELISA units/mL
Phase 4 N=17 Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Arteriovenous Fistula
Primary: Clotting TIme — 6; 8 minutes
Phase 4 N=71 Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
Ovarian Hyperstimulation Syndrome
Primary: Ongoing Pregnancy — 15; 19 participants
Phase 4 N=17 Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia
Schizophrenia
Primary: Food Consumption After Intervention — 7.9; 7.4 Grams
Phase 4 N=301 A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
HIV Prevention
Primary: Number of Participants With a Grade 2 or Higher Adverse Event by Cohort — 230; 0 Participants
Phase 4 N=19 Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
Multiple Sclerosis
Primary: Incidence of Infusion Related Reactions With Rapid Infusion Will be Reported — 0; 0 infusion reactions
Phase 4 N=60 Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6
PT-NANBH
Primary: Number of Participants With a Sustained Virologic Response (SVR) log10 HCV RNA PCR <25 IU/mL 12 Weeks Post-treatment — 19; 34; 4 Participants
Phase 4 N=20 Comparison of Two Different Surgical Approaches To Increase Peri-Implant Mucosa Thickness
Tooth Loss · Peri-implant Mucosa Defect
Primary: Change in Buccal Peri-implant Mucosa Thickness Between Baseline and 16 Weeks After Surgery — 0.44; 0.05 millimeters
Phase 4 N=153 Angiotensin II Blockade for Chronic Allograft Nephropathy
Kidney Disease · Proteinuria
Primary: Doubling of Interstitium or Any ESRD — 6; 12 Participants
Phase 4 N=525 Reducing Total Cardiovascular Risk in an Urban Community
Cardiovascular Diseases · Heart Diseases · Coronary Disease
Primary: Low-density Lipoprotein Cholesterol — 100.1; 110.6 mg/dL — p=<0.001
Phase 4 N=50 Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
Phase 4 N=12 Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
Acne
Primary: Plasma Minocycline Level — 421 ng/ml
Phase 4 N=80 Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia
Iron Deficiency Anemia
Primary: Hemoglobin Concentration Over Time — 7.7; 7.9; 9.3; 10.4 g/dL — p=<0.001